Grants

PI Name PI Organization Title Grant Number Initiative Program Director
Darie, Costel C.

Clarkson University
United States

PA-21-071 for Pathea Bruno to CA260126-01 Identifying a proteomic signature for breast cancer detection in breast milk and serum 3R15CA260126-01A1S1 Sharmistha Ghosh-Janjigian, Ph.D.
Majumder, Shounak

Mayo Clinic Rochester
United States

Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer 2U01CA210138-06 PAR-21-334 (U01 Clinical Trial Optional) Sharmistha Ghosh-Janjigian, Ph.D.
Majumder, Shounak

Mayo Clinic Rochester
United States

Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer 2U01CA210138-06 PAR-21-334 (U01 Clinical Trial Optional) Sharmistha Ghosh-Janjigian, Ph.D.
Hirsch, Fred R

Icahn School Of Medicine At Mount Sinai
United States

Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses 3U54CA260560-02S1 Guillermo Marquez, Ph.D.
Counter, Christopher M

Duke University
United States

PROMINENT-DUKE 1OT2CA278661-01 Sharmistha Ghosh-Janjigian, Ph.D.
Iyer, Prasad G.

Mayo Clinic Rochester
United States

Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma 5R01CA241164-04 Matthew Young, Ph.D.
Lundberg, Emma

Stanford University
United States

PROMINENT - Stanford 1OT2CA278713-01 Sharmistha Ghosh-Janjigian, Ph.D.
Borges, Chad R

Arizona State University-Tempe Campus
United States

Plate reader assays to forensically assess exposure of plasma and serum to thawed conditions 1R21CA269091-01 RFA-CA-21-005 (R21 Clinical Trial Not Allowed) Lynn Sorbara, Ph.D.
Agarwal, Ashutosh

University Of Miami School Of Medicine
United States

A comprehensive liquid biopsy platform for detection and prognostication in early stage breast cancer 5U01CA233363-05 Lynn Sorbara, Ph.D.
Sutcliffe, Julie L

University Of California At Davis
United States

Peptide-based targeted molecular imaging for early detection in pancreatic cancer 5U01CA217665-05 Matthew Young, Ph.D.